|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.48 SEK | -14.00% |
|
-35.37% | -48.57% |
| 07-17 | 19 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 07-17 | Orexos CEO Nikolaj Sørensen sums up Q2 2026 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OREXO AB | Specialty & Advanced Pharmaceuticals | -14.00% | -35.37% | -48.57% | -18.53% | -56.88% | 65.2M |  | | |
- Stock Market
- Stocks
- ORX Stock
- Charts Orexo AB
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
